| ISIN | CH0021722027 |
|---|---|
| Valor Number | 2172202 |
| Bloomberg Global ID | AMCEUEB SW |
| Fund Name | AMC PROFESSIONAL FUND - BCV Enhanced Europe Equity ESG B |
| Fund Provider |
Banque Cantonale Vaudoise
Lausanne, Switzerland Phone: +41 848 808 880 E-Mail: info@bcv.ch Web: www.bcv.ch |
| Fund Provider | Banque Cantonale Vaudoise |
| Representative in Switzerland | |
| Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
| Investment Strategy *** | BCV Enhanced Europe Equity ESG is focused on achieving long-term capital appreciation. This broadly diversified Sub-fund is managed according to a quantitative model-based approach. This approach aims to generate a moderate and consistent outperformance of the US stock market while limiting the relative risk of the latter. The Sub-fund invests in equities and other securities including dividend-right certificates, membership shares, participation certificates, and similar instruments of companies having their registered office in geographical Europe or exercising a preponderant part of their economic activity therein. The manager invests preferably in companies with a high ESG rating. The percentage invested in collective investment schemes is limited to a maximum of 10% of the Sub-fund's assets. |
| Peculiarities |
| Current Price * | 159.70 EUR | 04.12.2025 |
|---|---|---|
| Previous Price * | 158.87 EUR | 03.12.2025 |
| 52 Week High * | 161.17 EUR | 12.11.2025 |
| 52 Week Low * | 127.13 EUR | 09.04.2025 |
| NAV * | 159.70 EUR | 04.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 248,821,913 | |
| Unit/Share Assets *** | 17,276,017 | |
| Trading Information SIX | ||
| YTD Performance | +15.94% |
31.12.2024 - 04.12.2025
31.12.2024 04.12.2025 |
|---|---|---|
| YTD Performance (in CHF) | +15.41% |
31.12.2024 - 04.12.2025
31.12.2024 04.12.2025 |
| 1 month | +1.22% |
04.11.2025 - 04.12.2025
04.11.2025 04.12.2025 |
| 3 months | +6.04% |
04.09.2025 - 04.12.2025
04.09.2025 04.12.2025 |
| 6 months | +5.64% |
04.06.2025 - 04.12.2025
04.06.2025 04.12.2025 |
| 1 year | +13.78% |
04.12.2024 - 04.12.2025
04.12.2024 04.12.2025 |
| 2 years | +27.98% |
04.12.2023 - 04.12.2025
04.12.2023 04.12.2025 |
| 3 years | +38.33% |
05.12.2022 - 04.12.2025
05.12.2022 04.12.2025 |
| 5 years | +60.86% |
04.12.2020 - 04.12.2025
04.12.2020 04.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ASML Holding NV | 4.24% | |
|---|---|---|
| SAP SE | 2.75% | |
| AstraZeneca PLC | 2.41% | |
| HSBC Holdings PLC | 2.34% | |
| Siemens AG | 2.21% | |
| Schneider Electric SE | 1.63% | |
| Banco Santander SA | 1.61% | |
| Allianz SE | 1.61% | |
| Unilever PLC | 1.57% | |
| Novo Nordisk AS Class B | 1.47% | |
| Last data update | 31.10.2025 | |
| TER | 0.35% |
|---|---|
| TER date | 30.09.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.85% |
| Ongoing Charges *** | 0.34% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |